Is it necessary to plan with safety margins for actively scanned proton therapy?
- PMID: 21709340
- DOI: 10.1088/0031-9155/56/14/011
Is it necessary to plan with safety margins for actively scanned proton therapy?
Abstract
In radiation therapy, a plan is robust if the calculated and the delivered dose are in agreement, even in the case of different uncertainties. The current practice is to use safety margins, expanding the clinical target volume sufficiently enough to account for treatment uncertainties. This, however, might not be ideal for proton therapy and in particular when using intensity modulated proton therapy (IMPT) plans as degradation in the dose conformity could also be found in the middle of the target resulting from misalignments of highly in-field dose gradients. Single field uniform dose (SFUD) and IMPT plans have been calculated for different anatomical sites and the need for margins has been assessed by analyzing plan robustness to set-up and range uncertainties. We found that the use of safety margins is a good way to improve plan robustness for SFUD and IMPT plans with low in-field dose gradients but not necessarily for highly modulated IMPT plans for which only a marginal improvement in plan robustness could be detected through the definition of a planning target volume.
Similar articles
-
A robust algorithm of intensity modulated proton therapy for critical tissue sparing and target coverage.Phys Med Biol. 2011 Aug 7;56(15):4749-70. doi: 10.1088/0031-9155/56/15/008. Epub 2011 Jul 13. Phys Med Biol. 2011. PMID: 21753233
-
Experimental verification of IMPT treatment plans in an anthropomorphic phantom in the presence of delivery uncertainties.Phys Med Biol. 2011 Jul 21;56(14):4415-31. doi: 10.1088/0031-9155/56/14/012. Epub 2011 Jun 27. Phys Med Biol. 2011. PMID: 21709345
-
The influence of the optimization starting conditions on the robustness of intensity-modulated proton therapy plans.Phys Med Biol. 2010 May 21;55(10):2863-78. doi: 10.1088/0031-9155/55/10/005. Epub 2010 Apr 29. Phys Med Biol. 2010. PMID: 20427853
-
Robust Proton Treatment Planning: Physical and Biological Optimization.Semin Radiat Oncol. 2018 Apr;28(2):88-96. doi: 10.1016/j.semradonc.2017.11.005. Semin Radiat Oncol. 2018. PMID: 29735195 Free PMC article. Review.
-
Treatment planning optimisation in proton therapy.Br J Radiol. 2013 Jan;86(1021):20120288. doi: 10.1259/bjr.20120288. Br J Radiol. 2013. PMID: 23255545 Free PMC article. Review.
Cited by
-
Exploratory Study of 4D versus 3D Robust Optimization in Intensity Modulated Proton Therapy for Lung Cancer.Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):523-533. doi: 10.1016/j.ijrobp.2015.11.002. Epub 2015 Nov 10. Int J Radiat Oncol Biol Phys. 2016. PMID: 26725727 Free PMC article.
-
Proton vs photon: A model-based approach to patient selection for reduction of cardiac toxicity in locally advanced lung cancer.Radiother Oncol. 2020 Nov;152:151-162. doi: 10.1016/j.radonc.2019.06.032. Epub 2019 Aug 17. Radiother Oncol. 2020. PMID: 31431365 Free PMC article.
-
Evaluation of the inter- and intrafraction displacement for head patients treated at the particle therapy centre MedAustron based on the comparison of different commercial immobilisation devices.Z Med Phys. 2022 Feb;32(1):39-51. doi: 10.1016/j.zemedi.2021.01.007. Epub 2021 Feb 24. Z Med Phys. 2022. PMID: 33640219 Free PMC article.
-
Fast range-corrected proton dose approximation method using prior dose distribution.Phys Med Biol. 2012 Jun 7;57(11):3555-69. doi: 10.1088/0031-9155/57/11/3555. Epub 2012 May 16. Phys Med Biol. 2012. PMID: 22588165 Free PMC article.
-
Influence of robust optimization in intensity-modulated proton therapy with different dose delivery techniques.Med Phys. 2012 Jun;39(6):3089-101. doi: 10.1118/1.4711909. Med Phys. 2012. PMID: 22755694 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical